Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level

Perkiö, Anna; Pradhan, Barun; Genc, Fatih; Pirttikoski, Anna; Pikkusaari, Sanna; Erkan, Erdogan Pekcan; Falco, Matias Marin; Huhtinen, Kaisa; Narva, Sara; Hynninen, Johanna; Kauppi, Liisa; Vähärautio, Anna (2024-02)

 
Avaa tiedosto
s41598-024-54113-w.pdf (2.281Mt)
Lataukset: 



Perkiö, Anna
Pradhan, Barun
Genc, Fatih
Pirttikoski, Anna
Pikkusaari, Sanna
Erkan, Erdogan Pekcan
Falco, Matias Marin
Huhtinen, Kaisa
Narva, Sara
Hynninen, Johanna
Kauppi, Liisa
Vähärautio, Anna
02 / 2024

Scientific Reports
4322
doi:10.1038/s41598-024-54113-w
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202404053319

Kuvaus

Peer reviewed
Tiivistelmä
Long interspersed nuclear elements (LINE-1s/L1s) are a group of retrotransposons that can copy themselves within a genome. In humans, it is the most successful transposon in nucleotide content. L1 expression is generally mild in normal human tissues, but the activity has been shown to increase significantly in many cancers. Few studies have examined L1 expression at single-cell resolution, thus it is undetermined whether L1 reactivation occurs solely in malignant cells within tumors. One of the cancer types with frequent L1 activity is high-grade serous ovarian carcinoma (HGSOC). Here, we identified locus-specific L1 expression with 3′ single-cell RNA sequencing in pre- and post-chemotherapy HGSOC sample pairs from 11 patients, and in fallopian tube samples from five healthy women. Although L1 expression quantification with the chosen technique was challenging due to the repetitive nature of the element, we found evidence of L1 expression primarily in cancer cells, but also in other cell types, e.g. cancer-associated fibroblasts. The expression levels were similar in samples taken before and after neoadjuvant chemotherapy, indicating that L1 transcriptional activity was unaffected by clinical platinum-taxane treatment. Furthermore, L1 activity was negatively associated with the expression of MYC target genes, a finding that supports earlier literature of MYC being an L1 suppressor.
Kokoelmat
  • TUNICRIS-julkaisut [23422]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste